Cargando…

Empirical evidence of disease activity thresholds used to indicate need for major therapeutic change in US veterans with rheumatoid arthritis

BACKGROUND: A previous analysis of the Veterans Affairs Rheumatoid Arthritis (VARA) registry showed that more than half of the patients with rheumatoid arthritis (RA) did not receive a major therapeutic change (MTC) despite moderate or severe disease activity. We aimed to empirically determine disea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sauer, Brian C., Chen, Wei, Xu, Yizhe, Shen, Jincheng, Accortt, Neil A., Collier, David H., Cannon, Grant W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579862/ https://www.ncbi.nlm.nih.gov/pubmed/33092642 http://dx.doi.org/10.1186/s13075-020-02346-1

Ejemplares similares

Models solely using claims-based administrative data are poor predictors of rheumatoid arthritis disease activity
por: Sauer, Brian C., et al.
Publicado: (2017)

Clinical Outcomes and Biologic Costs of Switching Between Tumor Necrosis Factor Inhibitors in US Veterans with Rheumatoid Arthritis
por: Cannon, Grant W., et al.
Publicado: (2016)

Persistence With Conventional Triple Therapy Versus a Tumor Necrosis Factor Inhibitor and Methotrexate in US Veterans With Rheumatoid Arthritis
por: Sauer, Brian C., et al.
Publicado: (2017)

Validation of Diagnostic and Procedural Codes for Identification of Acute Cardiovascular Events in US Veterans with Rheumatoid Arthritis
por: Davis, Lisa A., et al.
Publicado: (2014)

Trends of lymphoma incidence in US veterans with rheumatoid arthritis, 2002–2017
por: Singh, Namrata, et al.
Publicado: (2020)

Subsequent Cardiovascular Events Among Patients With Rheumatoid Arthritis, Psoriatic Arthritis, or Psoriasis: Patterns of Disease‐Modifying Antirheumatic Drug Treatment
por: Sparks, Jeffrey A., et al.
Publicado: (2019)

Changes in Patterns of Use of Advanced Therapies Following Emerging Data About Adverse Events in Patients With Rheumatoid Arthritis From the Veterans Affairs Health System
por: Jeong, Stephanie, et al.
Publicado: (2023)

Lowering Expectations: Glucocorticoid Tapering Among Veterans With Rheumatoid Arthritis Achieving Low Disease Activity on Stable Biologic Therapy
por: Wallace, Beth I., et al.
Publicado: (2023)

Changes in Healthcare Utilization After Etanercept Initiation in Patients with Rheumatoid Arthritis: A Retrospective Claims Analysis
por: Accortt, Neil A., et al.
Publicado: (2017)

Impact of Sustained Remission on the Risk of Serious Infection in Patients With Rheumatoid Arthritis
por: Accortt, Neil A., et al.
Publicado: (2018)

Dose relationship between oral glucocorticoids and tumor necrosis factor inhibitors and the risk of hospitalized infectious events among patients with rheumatoid arthritis
por: Schenfeld, Jennifer, et al.
Publicado: (2017)

Blood glucose changes surrounding initiation of tumor-necrosis factor inhibitors and conventional disease-modifying anti-rheumatic drugs in veterans with rheumatoid arthritis
por: Wood, Patrick R, et al.
Publicado: (2018)

Unmet needs in rheumatoid arthritis
por: Moreland, Larry
Publicado: (2005)

Extraction of Rheumatoid Arthritis Disease Activity Measures From Electronic Health Records Using Automated Processing Algorithms
por: Cannon, Grant W., et al.
Publicado: (2019)

Vaccinating Veterans for COVID-19 at the U.S. Department of Veterans Affairs
por: Der-Martirosian, Claudia, et al.
Publicado: (2022)

Maintenance of Sustained Low Disease Activity or Remission in Patients With Rheumatoid Arthritis Treated With Etanercept Monotherapy: Results from the Corrona Registry
por: Pappas, Dimitrios A., et al.
Publicado: (2020)

Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration
por: Navarro-Millán, Iris, et al.
Publicado: (2016)

Persistence on biologic DMARD monotherapy after achieving rheumatoid arthritis disease control on combination therapy: retrospective analysis of corrona registry data
por: Pappas, Dimitrios A., et al.
Publicado: (2020)

How do physicians decide to treat: an empirical evaluation of the threshold model
por: Djulbegovic, Benjamin, et al.
Publicado: (2014)

The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis
por: Chen, Fangfang, et al.
Publicado: (2023)

Evidence for an Inherited Contribution to Sepsis Susceptibility Among a Cohort of U.S. Veterans
por: Kempker, Jordan A., et al.
Publicado: (2022)

Machine learning identification of thresholds to discriminate osteoarthritis and rheumatoid arthritis synovial inflammation
por: Mehta, Bella, et al.
Publicado: (2023)

Correction to: The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis
por: Chen, Fangfang, et al.
Publicado: (2023)

Knee alterations in rheumatoid arthritis: Comparison of US and MRI
por: Xiao, Lu, et al.
Publicado: (2021)

Delivering fracture prevention services to rural US veterans through telemedicine: a process evaluation
por: Miller, Karla L., et al.
Publicado: (2021)

Durability of Response to Tocilizumab Therapy in Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry
por: Pappas, Dimitrios A., et al.
Publicado: (2021)

Positive effect of hydroxychloroquine on lipid profiles of patients with rheumatoid arthritis: A Veterans Affair cohort
por: Guevara, Myriam, et al.
Publicado: (2021)

Conditional analysis of the major histocompatibility complex in rheumatoid arthritis
por: Taylor, Kimberly E, et al.
Publicado: (2009)

Declining needs for total joint replacements for rheumatoid arthritis
por: Khan, Nasim A, et al.
Publicado: (2011)

Patient satisfaction with medication in rheumatoid arthritis: an unmet need
por: Miladi, Saoussen, et al.
Publicado: (2023)

Empirically derived subgroups in rheumatoid arthritis: association with single-nucleotide polymorphisms on chromosome 6
por: Wilcox, Marsha A, et al.
Publicado: (2007)

Clinical and treatment characteristics of patients treated with the first therapeutic oncology biosimilars bevacizumab-awwb and trastuzumab-anns in the US
por: Jin, Ran, et al.
Publicado: (2021)

Understanding the Needs of Veterans with PTSD
por: Murphy, Dominic M., et al.
Publicado: (2018)

Chinese Registry of rheumatoid arthritis (CREDIT): II. prevalence and risk factors of major comorbidities in Chinese patients with rheumatoid arthritis
por: Jin, Shangyi, et al.
Publicado: (2017)

Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis
por: Mal, Kheraj, et al.
Publicado: (2020)

The Economic Benefit of Remission for Patients with Rheumatoid Arthritis
por: Curtis, Jeffrey R., et al.
Publicado: (2022)

Predictors of fatigue in rheumatoid arthritis
por: Druce, Katie L, et al.
Publicado: (2019)

Obesity and Morbidity Risk in the U.S. Veteran
por: Betancourt, Jose A., et al.
Publicado: (2020)

Severe Periodontitis Is a Major Contributory Factor to Unmet Dental Healthcare Needs among Rheumatoid Arthritis Patients in Hong Kong
por: Mok, Mo Yin, et al.
Publicado: (2022)

Recognizing the Needs of High-Need High-Risk Veterans
por: Dang, Stuti, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9r8ap6mivm4vpk09qra261k1bq